At a glance
ClinicalIndex Comparison RecordN/ACompleted· 570 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Early-Onset Sepsis an NICHD/CDC Surveillance Study
In Brief
An observational study for Infant, Newborn, Diseases and 2 related conditions. Completed, enrolled 570 participants across 20 sites.
Detailed Summary
This prospective surveillance study will be conducted over a 2 year period to determine current rates of Early-Onset Sepsis (EOS)/ Early-Onset Meningitis (EOM), associated pathogens, antimicrobial resistance, signs and symptoms and infant outcomes.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartApr 2015
First PostedApr 2015
Primary CompletionDec 2017
TodayJul 2026
First PostedApr 7, 2015
Enrollment StartApr 1, 2015
Primary CompletionDec 1, 2017
TodayJul 1, 2026
Enrollment to primary: 2.7 yearsPosted 11.2 years ago